Senate Reform Bill Includes Tax Credit For Dx, Drug-Delivery Investments
This article was originally published in The Gray Sheet
Executive Summary
Companies with 250 or fewer employees would be eligible for a 50% tax credit on 2009-2010 investments in certain diagnostics, drug-delivery devices and pharmaceuticals under a provision in the Senate's health care reform bill